28662003: Hydralazine hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\agent cardiovasculaire\Hypotensive agent (substance)\Vasodilator (substance)\Hydralazine hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Hydrazine and/or hydrazine derivative\Hydralazine hydrochloride

\Organic compound\Organic nitrogen compound\Hydrazine and/or hydrazine derivative\Hydralazine hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hydralazine hydrochloride	Is a	Hydralazine-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride	Is a	Vasodilator (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride	Is a	Hydralazine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride	Is modification of (attribute)	Hydralazine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride	Is a	Hydrazine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride	Is a	Hydrazine and/or hydrazine derivative	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Hydralazine hydrochloride 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 20mg injection (pdr for recon) (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride + hydrochlorothiazide 100mg/50mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing hydralazine hydrochloride and hydrochlorothiazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydralazine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride + hydrochlorothiazide 100mg/50mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride + hydrochlorothiazide 100mg/50mg capsule	Has basis of strength substance (attribute)	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 100 mg oral tablet	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydralazine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydralazine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg oral tablet	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 50 mg oral tablet	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride + hydrochlorothiazide 100mg/50mg capsule	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule	Has basis of strength substance (attribute)	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has basis of strength substance (attribute)	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride 100 mg oral tablet	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydralazine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg oral tablet	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 50 mg oral tablet	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydralazine hydrochloride + hydrochlorothiazide 100mg/50mg capsule	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule	Has precise active ingredient	False	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely hydralazine hydrochloride 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely hydralazine hydrochloride 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule	Has basis of strength substance (attribute)	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule	Has precise active ingredient	True	Hydralazine hydrochloride	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
47984012	Hydralazine hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
759366010	Hydralazine hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
47984012	Hydralazine hydrochloride	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
47984012	Hydralazine hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
759366010	Hydralazine hydrochloride (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
759366010	Hydralazine hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
862641000172117	chlorhydrate d'hydralazine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
862641000172117	chlorhydrate d'hydralazine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module